Tristan Ferry

Background

About Tristan Ferry

Tristan Ferry graduated from the Claude Bernard Lyon 1 University, Lyon, France and has trained in Internal Medicine and Infectious and Tropical Diseases in Hospices Civils de Lyon, France (Dr. med. obtained in 2006). He obtained a PhD thesis in 2007 and obtained the degree “Habilitation à Diriger les Recherches” (HDR, the French post-doctoral degree allowing its holder to supervise PhD students) in 2011 (Claude Bernard Lyon 1 University). He completed his postgraduate studies in Geneva, Switzerland by working in the field on HIV and S. aureus bone and joint infections (BJI). Currently, he is the co-head of the Infectious and Tropical disease unit in Hospices Civils de Lyon (43 beds including 1 high-level isolation bed), is head of the regional reference center for the management of complex BJI (also called CRIOAc Lyon; http://CRIOAc-lyon.fr), the Head of the Lyon BJI group (a multidisciplinary group with colleagues specialized in infectious disease, surgery, microbiology, imaging, nuclear medicine and drug’s pharmacokinetic). His main topic of research is the promotion of innovative treatments, by systemic and/or local administrations in patients with bone and joint infection. He is particularly involved in the promotion and evaluation of bacteriophage/phagotherapy and combination of local antibiotics in patients with bone and joint infection. By becoming President of the national CRIOAc scientific committee, board member of EBJIS and clinical officer of the ESCMID study group for non traditional antibacterial therapy, he would like to facilitate the performance of multicentric clinical trials in France and in Europe, to evaluate academic and industrial new treatment options.